Change
Tools:
Print this page Compare to last year's report

Financial highlights


Revenue was down 4 percent due to divestments and adverse currencies. Operating income was 17 percent lower at €322 million, driven by adverse price/mix developments. Specialty Chemicals were impacted by a general softening of demand across all markets. Cash from operating activities was €261 million (2012: €351 million), mainly due to lower operating income.

Summary of financial outcomes

2nd quarter

 

 

 

 

 

 

 

January - June

2012

 

2013

 

Δ%

 

in € millions

 

2012

 

2013

 

Δ%

4,044

 

3,865

 

(4)

 

Revenue

 

7,751

 

7,330

 

(5)

388

 

322

 

(17)

 

Operating income

 

624

 

539

 

(14)

9.6

 

8.3

 

 

 

ROS%

 

8.1

 

7.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Invested capital

 

12,684

 

10,239

 

 

 

 

 

 

 

 

Moving average ROI (in %)

 

8.7

 

7.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

554

 

474

 

(14)

 

EBITDA

 

964

 

849

 

(12)

166

 

168

 

 

 

Capital expenditures

 

301

 

299

 

 

351

 

261

 

 

 

Net cash from operating activities

 

(353)

 

(145)

 

 

 

 

 

 

 

 

Net debt

 

2,844

 

2,197

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

215

 

308

 

43

 

Net income from continuing operations

 

325

 

404

 

24

4

 

121

 

 

 

Net income from discontinued operations

 

(22)

 

114

 

 

219

 

429

 

96

 

Net income attributable to shareholders

 

303

 

518

 

71

0.92

 

1.78

 

 

 

Earnings per share from total operations (in €)

 

1.28

 

2.15

 

 

1.06

 

1.37

 

 

 

Adjusted earnings per share (in €)

 

1.71

 

1.89

 

 

 

 

 

 

 

 

Number of employees

 

52,820

 

50,500

 

 

Copyright © 2013 Akzo Nobel N.V.